NASDAQ: CMRX. $0.90. -0.0201 (-2.18%). 435,600. Apr 17, 2024 3:30 PM EDT. Data Provided by Refinitiv. Minimum 15 minutes delayed. 1M; 3M ...
Learn more about our approach to investing in novel drug ... Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update.
Find annual and quearterly earnings data for Chimerix, Inc. Common Stock (CMRX) including earnings per share, earnings forecasts at Nasdaq.com.
Find the latest institutional holdings data for Chimerix, Inc. Common Stock (CMRX) including shareholders, ownership summaries, and holding activities at ...
Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 7, 2023 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
CMRX - Chimerix, Inc. NasdaqGM - NasdaqGM Real ... CMRX), a biopharmaceutical ... Investor Relations, to Chief Financial Officer effective December 1, 2023.